The patient with chronic kidney disease (CKD) represents an extreme model for
arteriosclerosis, vascular calcification, and bone disorders, all of which are also associated …

Background In patients with end stage kidney disease (ESKD) on dialysis, treatment non-
adherence is common and results in poor health outcomes. However, the clinical benefits of …

Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for nutrition in kidney diseases since …

Hyperphosphatemia has consistently been shown to be associated with dismal outcome in a
wide variety of populations, particularly in chronic kidney disease (CKD). Compelling …

The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline
Update for the Diagnosis, Evaluation, Prevention, and Treatment of chronic kidney disease …

Mineral and bone disorders (MBD) are common in patients with chronic kidney disease
(CKD), contributing to significant morbidity and mortality. For several decades, the first-line …

Nonadherence to therapy (dietary/fluid restrictions, medications, and dialysis treatment), is
common in patients with end‐stage kidney disease (ESKD) undergoing dialysis. It is …

Background Chronic kidney disease‐mineral and bone disorder (CKD‐MBD) is a systemic
dysfunction of mineral and bone metabolism in people with CKD. Recent research shows …

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and
Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) - PMC Back to …

Results Of the 8054 titles/abstracts identified, 168 articles were reviewed, and 12 clinical
trials (11 randomized, one nonrandomized) were included. Diet therapy reduced serum …